Trial
NCT00701701
Immune Tolerance Induction Study
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Genzyme, a Sanofi Company
Collaborators
—
Condition
Pompe Disease
Intervention
Myozyme® (alglucosidase alfa)
Why stopped
Study was conducted to fulfill a post marketing commitment (PMC 6). FDA acknowledged fulfillment of PMC.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-07